Hims & Hers Health target price cut to $24 from $32 by JP Morgan
HIMS•JP Morgan cut its target price for Hims & Hers Health to $24 from $32.
Related News
China AI firms face barriers to global expansion, MTR Lab says
QQQ•
Lipocine doses first participant in Phase 3 trial of LPCN 1154 for postpartum depression
LPCN•
OPC Energy Q3 adjusted net income more than doubles to $126 million
KEN•
Estée Lauder: Citigroup raises target price to $132 from $121
EL•
Vivid Seats Inc: StoneX cuts target price to $4 from $16
SEAT•